CT
TEVA icon

Clearstead Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Clearstead Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$2K – 204
2019
Q1 		$2K Hold
100
– – ﹤0.01% 181
2018
Q4 		$2K Hold
100
– – ﹤0.01% 210
2018
Q3 		$2K Hold
100
– – ﹤0.01% 188
2018
Q2 		$2K Buy
+100
New +$2.04K ﹤0.01% 192
2018
Q1 		– Sell
-100
Closed -$2K – 181
2017
Q4 		$2K Hold
100
– – ﹤0.01% 199
2017
Q3 		$2K Hold
100
– – ﹤0.01% 210
2017
Q2 		$3K Buy
+100
New +$3.1K ﹤0.01% 227

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Clearstead Trust's TEVA Position: Q2 2019 in Review

Clearstead Trust sold out of Teva Pharmaceuticals (TEVA) in Q2 2019, closing a stake of 100 shares — an estimated $2K sold.

Clearstead Trust first reported a position in TEVA in Q2 2017 and held it in 7 quarters. The position peaked at $3K in Q2 2017. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

  • Clearstead Trust reported no remaining Teva Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Clearstead Trust sold 100 Teva Pharmaceuticals shares in Q2 2019, an estimated $2K.
  • Clearstead Trust first reported a position in Teva Pharmaceuticals in Q2 2017 and held it in 7 quarters.
  • Clearstead Trust's Teva Pharmaceuticals position peaked at $3K in Q2 2017.
  • 452 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2019.

Based on Clearstead Trust's 13F filing for Q2 2019, filed 31 Jul 2019.